TCG Crossover Management, LLC
Position in GPCR — Structure Therapeutics Inc.
CIK 1839948
PALO ALTO, CA
Position in GPCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,767,810
-$57,277,794 QoQ
Shares Held
140,411
-84.8% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GPCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TCG Crossover Management, LLC holds $3,218,747,876 across 44 Biotechnology names. GPCR ranks #39 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
6,481,085 | $721,668,814 | |
| 2 | CGON |
CG Oncology, Inc.
|
3,670,206 | $248,399,542 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
10,531,071 | $220,310,005 | |
| 4 | COGT |
Cogent Biosciences, Inc.
|
4,946,894 | $190,405,950 | |
| 5 | CNTA |
Centessa Pharmaceuticals plc
|
4,286,480 | $170,258,985 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
1,676,624 | $140,702,286 | |
| 7 | TYRA |
Tyra Biosciences, Inc.
|
3,248,980 | $124,435,934 | |
| 8 | IMVT |
Immunovant, Inc.
|
4,457,988 | $110,736,421 |
All Filings in GPCR
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,767,810 | 140,411 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $64,045,604 | 920,857 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $29,764,000 | 1,063,000 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $22,046,620 | 1,063,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $18,400,530 | 1,063,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $28,828,560 | 1,063,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $46,655,070 | 1,063,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $27,274,860 | 694,547 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $68,508,324 | 1,598,421 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $85,986,643 | 2,109,584 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $75,768,503 | 1,502,747 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $14,549,500 | 350,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $8,326,500 | 350,000 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||